468 related articles for article (PubMed ID: 24735980)
1. Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.
Perluigi M; Pupo G; Tramutola A; Cini C; Coccia R; Barone E; Head E; Butterfield DA; Di Domenico F
Biochim Biophys Acta; 2014 Jul; 1842(7):1144-53. PubMed ID: 24735980
[TBL] [Abstract][Full Text] [Related]
2. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
3. mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia.
Di Domenico F; Tramutola A; Foppoli C; Head E; Perluigi M; Butterfield DA
Free Radic Biol Med; 2018 Jan; 114():94-101. PubMed ID: 28807816
[TBL] [Abstract][Full Text] [Related]
4. Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: redox proteomics analysis of human brain.
Di Domenico F; Coccia R; Cocciolo A; Murphy MP; Cenini G; Head E; Butterfield DA; Giorgi A; Schinina ME; Mancuso C; Cini C; Perluigi M
Biochim Biophys Acta; 2013 Aug; 1832(8):1249-59. PubMed ID: 23603808
[TBL] [Abstract][Full Text] [Related]
5. Exploring the molecular mechanisms of MSC-derived exosomes in Alzheimer's disease: Autophagy, insulin and the PI3K/Akt/mTOR signaling pathway.
Ebrahim N; Al Saihati HA; Alali Z; Aleniz FQ; Mahmoud SYM; Badr OA; Dessouky AA; Mostafa O; Hussien NI; Farid AS; El-Sherbiny M; Salim RF; Forsyth NR; Ali FEM; Alsabeelah NF
Biomed Pharmacother; 2024 Jul; 176():116836. PubMed ID: 38850660
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice.
Wang C; Zhang X; Teng Z; Zhang T; Li Y
Eur J Pharmacol; 2014 Oct; 740():312-20. PubMed ID: 25041840
[TBL] [Abstract][Full Text] [Related]
7. Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.
Cenini G; Dowling AL; Beckett TL; Barone E; Mancuso C; Murphy MP; Levine H; Lott IT; Schmitt FA; Butterfield DA; Head E
Biochim Biophys Acta; 2012 Feb; 1822(2):130-8. PubMed ID: 22009041
[TBL] [Abstract][Full Text] [Related]
8. Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.
Di Domenico F; Pupo G; Tramutola A; Giorgi A; Schininà ME; Coccia R; Head E; Butterfield DA; Perluigi M
Free Radic Biol Med; 2014 Jun; 71():270-280. PubMed ID: 24675226
[TBL] [Abstract][Full Text] [Related]
9. The PI3K/Akt signaling axis in Alzheimer's disease: a valuable target to stimulate or suppress?
Razani E; Pourbagheri-Sigaroodi A; Safaroghli-Azar A; Zoghi A; Shanaki-Bavarsad M; Bashash D
Cell Stress Chaperones; 2021 Nov; 26(6):871-887. PubMed ID: 34386944
[TBL] [Abstract][Full Text] [Related]
10. Schizandrol A protects against Aβ
Song L; Yao L; Zhang L; Piao Z; Lu Y
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1739-1752. PubMed ID: 31900522
[TBL] [Abstract][Full Text] [Related]
11. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
12. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
[TBL] [Abstract][Full Text] [Related]
13. Tadalafil and bergapten mitigate streptozotocin-induced sporadic Alzheimer's disease in mice via modulating neuroinflammation, PI3K/Akt, Wnt/β-catenin, AMPK/mTOR signaling pathways.
Salem MA; Budzyńska B; Kowalczyk J; El Sayed NS; Mansour SM
Toxicol Appl Pharmacol; 2021 Oct; 429():115697. PubMed ID: 34428446
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.
Moncaster JA; Pineda R; Moir RD; Lu S; Burton MA; Ghosh JG; Ericsson M; Soscia SJ; Mocofanescu A; Folkerth RD; Robb RM; Kuszak JR; Clark JI; Tanzi RE; Hunter DG; Goldstein LE
PLoS One; 2010 May; 5(5):e10659. PubMed ID: 20502642
[TBL] [Abstract][Full Text] [Related]
15. Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.
Tramutola A; Pupo G; Di Domenico F; Barone E; Arena A; Lanzillotta C; Brokeaart D; Blarzino C; Head E; Butterfield DA; Perluigi M
J Alzheimers Dis; 2016; 52(1):359-371. PubMed ID: 26967221
[TBL] [Abstract][Full Text] [Related]
16. [Moxibustion at acpoints of governor vessel on regulating PI3K/Akt/mTOR signaling pathway and enhancing autophagy process in APP/PS1 double-transgenic Alzheimer's disease mice].
Zhang LD; Han W; Zhu CF; Song XG; Cheng H; Yang K; Qin XF; Zhang JY; Gui L
Zhongguo Zhen Jiu; 2019 Dec; 39(12):1313-8. PubMed ID: 31820607
[TBL] [Abstract][Full Text] [Related]
17. Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome.
Cárdenas AM; Ardiles AO; Barraza N; Baéz-Matus X; Caviedes P
Arch Med Res; 2012 Nov; 43(8):645-54. PubMed ID: 23142525
[TBL] [Abstract][Full Text] [Related]
18. PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy.
Fan S; Zhang B; Luan P; Gu B; Wan Q; Huang X; Liao W; Liu J
Biomed Res Int; 2015; 2015():161020. PubMed ID: 26583091
[TBL] [Abstract][Full Text] [Related]
19. Cryptotanshinone Attenuates Amyloid-β
Lyu D; Jia J
Mol Neurobiol; 2022 Jul; 59(7):4488-4500. PubMed ID: 35575872
[TBL] [Abstract][Full Text] [Related]
20. Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid.
Portelius E; Soininen H; Andreasson U; Zetterberg H; Persson R; Karlsson G; Blennow K; Herukka SK; Mattsson N
Neurodegener Dis; 2014; 14(2):98-106. PubMed ID: 24992945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
